Literature DB >> 21481039

Pulse exposure of haematopoietic grafts to prostaglandin E2 in vitro facilitates engraftment and recovery.

L M Pelus1, J Hoggatt, P Singh.   

Abstract

OBJECTIVES: The aim of this study was to evaluate the effects of prostaglandin E(2) (PGE(2) ) on haematopoietic stem cell (HSC) function and determine its mechanism of action.
MATERIALS AND METHODS: HSC were exposed to PGE(2) for 2 h and effects on their homing, engraftment and self-renewal evaluated in vivo. Effects of PGE(2) on HSC cell cycle, CXCR4 expression and migration to SDF-1α were analysed in vitro. Apoptosis was evaluated by examination of survivin expression and active caspase-3 levels.
RESULTS: Equivalent haematopoietic reconstitution was demonstrated using 4-fold fewer PGE(2) -treated cells compared to controls. Multilineage reconstitution was stable on secondary transplantation, indicating that PGE(2) affects long-term repopulating HSC (LT-HSC) and that enhanced chimaerism of PGE(2) -pulsed cells results from their initial treatment. PGE(2) increased CXCR4 expression on mouse and human HSC, increased their migration to SDF-1αin vitro and enhanced in vivo marrow homing 2-fold, which was blocked by a CXCR4 receptor antagonist. PGE(2) pulse exposure reduced apoptosis of mouse and human HSC, with increase in endogenous caspase inhibitor survivin, and concomitant decrease in active caspase-3. Two-fold more HSC entered the cell cycle and proliferated within 24 h after PGE(2) pulse exposure.
CONCLUSIONS: These studies demonstrate that short-term PGE(2) exposure enhances HSC function and supports the concept of utility of PGE(2) as an ex vivo strategy to improve function of haematopoietic grafts, particularly those where HSC numbers are limited.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21481039      PMCID: PMC6372373          DOI: 10.1111/j.1365-2184.2010.00726.x

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  18 in total

Review 1.  Optimizing autologous cell grafts to improve stem cell gene therapy.

Authors:  Nikoletta Psatha; Garyfalia Karponi; Evangelia Yannaki
Journal:  Exp Hematol       Date:  2016-04-19       Impact factor: 3.084

2.  TISSUE REGENERATION. Inhibition of the prostaglandin-degrading enzyme 15-PGDH potentiates tissue regeneration.

Authors:  Yongyou Zhang; Amar Desai; Sung Yeun Yang; Ki Beom Bae; Monika I Antczak; Stephen P Fink; Shruti Tiwari; Joseph E Willis; Noelle S Williams; Dawn M Dawson; David Wald; Wei-Dong Chen; Zhenghe Wang; Lakshmi Kasturi; Gretchen A Larusch; Lucy He; Fabio Cominelli; Luca Di Martino; Zora Djuric; Ginger L Milne; Mark Chance; Juan Sanabria; Chris Dealwis; Debra Mikkola; Jacinth Naidoo; Shuguang Wei; Hsin-Hsiung Tai; Stanton L Gerson; Joseph M Ready; Bruce Posner; James K V Willson; Sanford D Markowitz
Journal:  Science       Date:  2015-06-12       Impact factor: 47.728

Review 3.  Pleiotropic effects of prostaglandin E2 in hematopoiesis; prostaglandin E2 and other eicosanoids regulate hematopoietic stem and progenitor cell function.

Authors:  Louis M Pelus; Jonathan Hoggatt
Journal:  Prostaglandins Other Lipid Mediat       Date:  2011-06-21       Impact factor: 3.072

4.  Unsaturated fatty acids induce mesenchymal stem cells to increase secretion of angiogenic mediators.

Authors:  Andria N Smith; Lara A Muffley; Austin N Bell; Surawej Numhom; Anne M Hocking
Journal:  J Cell Physiol       Date:  2012-09       Impact factor: 6.384

5.  Prostaglandin E2 increases hematopoietic stem cell survival and accelerates hematopoietic recovery after radiation injury.

Authors:  Rebecca L Porter; Mary A Georger; Olga Bromberg; Kathleen E McGrath; Benjamin J Frisch; Michael W Becker; Laura M Calvi
Journal:  Stem Cells       Date:  2013-02       Impact factor: 6.277

6.  Inhibitors of 15-Prostaglandin Dehydrogenase To Potentiate Tissue Repair.

Authors:  Monika I Antczak; Yongyou Zhang; Changguang Wang; Jennifer Doran; Jacinth Naidoo; Sukesh Voruganti; Noelle S Williams; Sanford D Markowitz; Joseph M Ready
Journal:  J Med Chem       Date:  2017-04-25       Impact factor: 7.446

7.  Meloxicam with Filgrastim may Reduce Oxidative Stress in Hematopoietic Progenitor Cells during Mobilization of Autologous Peripheral Blood Stem Cells in Patients with Multiple Myeloma.

Authors:  Andrea M Patterson; Shuhong Zhang; Liqiong Liu; Hongge Li; Pratibha Singh; Yunlong Liu; Sherif S Farag; Louis M Pelus
Journal:  Stem Cell Rev Rep       Date:  2021-09-12       Impact factor: 5.739

8.  Recovery from hematopoietic injury by modulating prostaglandin E(2) signaling post-irradiation.

Authors:  Jonathan Hoggatt; Pratibha Singh; Kayla N Stilger; P Artur Plett; Carol H Sampson; Hui Lin Chua; Christie M Orschell; Louis M Pelus
Journal:  Blood Cells Mol Dis       Date:  2012-11-30       Impact factor: 3.039

9.  Prostaglandin-modulated umbilical cord blood hematopoietic stem cell transplantation.

Authors:  Corey Cutler; Pratik Multani; David Robbins; Haesook T Kim; Thuy Le; Jonathan Hoggatt; Louis M Pelus; Caroline Desponts; Yi-Bin Chen; Betsy Rezner; Philippe Armand; John Koreth; Brett Glotzbecker; Vincent T Ho; Edwin Alyea; Marlisa Isom; Grace Kao; Myriam Armant; Leslie Silberstein; Peirong Hu; Robert J Soiffer; David T Scadden; Jerome Ritz; Wolfram Goessling; Trista E North; John Mendlein; Karen Ballen; Leonard I Zon; Joseph H Antin; Daniel D Shoemaker
Journal:  Blood       Date:  2013-08-30       Impact factor: 22.113

10.  Prostaglandin E2 Enhances Aged Hematopoietic Stem Cell Function.

Authors:  Andrea M Patterson; P Artur Plett; Carol H Sampson; Edward Simpson; Yunlong Liu; Louis M Pelus; Christie M Orschell
Journal:  Stem Cell Rev Rep       Date:  2021-05-11       Impact factor: 5.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.